BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38417098)

  • 1. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
    Jaiyesimi IA; Leighl NB; Ismaila N; Alluri K; Florez N; Gadgeel S; Masters G; Schenk EL; Schneider BJ; Sequist L; Singh N; Bazhenova L; Blanchard E; Freeman-Daily J; Furuya N; Halmos B; Azar IH; Kuruvilla S; Mullane M; Naidoo J; Reuss JE; Spigel DR; Owen DH; Patel JD
    J Clin Oncol; 2024 Apr; 42(11):e23-e43. PubMed ID: 38417098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
    Jaiyesimi IA; Leighl NB; Ismaila N; Alluri K; Florez N; Gadgeel S; Masters G; Schenk EL; Schneider BJ; Sequist L; Singh N; Bazhenova L; Blanchard E; Freeman-Daily J; Furuya N; Halmos B; Azar IH; Kuruvilla S; Mullane M; Naidoo J; Reuss JE; Spigel DR; Owen DH; Patel JD
    J Clin Oncol; 2024 Apr; 42(11):e1-e22. PubMed ID: 38417091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
    Hanna NH; Robinson AG; Temin S; Baker S; Brahmer JR; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Moffitt PR; Phillips T; Riely GJ; Rosell R; Schiller JH; Schneider BJ; Singh N; Spigel DR; Tashbar J; Masters G
    J Clin Oncol; 2021 Mar; 39(9):1040-1091. PubMed ID: 33591844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
    Hanna NH; Schneider BJ; Temin S; Baker S; Brahmer J; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Phillips T; Riely GJ; Robinson AG; Rosell R; Schiller JH; Singh N; Spigel DR; Stabler JO; Tashbar J; Masters G
    J Clin Oncol; 2020 May; 38(14):1608-1632. PubMed ID: 31990617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
    Daly ME; Singh N; Ismaila N; Antonoff MB; Arenberg DA; Bradley J; David E; Detterbeck F; Früh M; Gubens MA; Moore AC; Padda SK; Patel JD; Phillips T; Qin A; Robinson C; Simone CB
    J Clin Oncol; 2022 Apr; 40(12):1356-1384. PubMed ID: 34936470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
    Khurshid H; Ismaila N; Bian J; Dabney R; Das M; Ellis P; Feldman J; Hann C; Kulkarni S; Laskin J; Manochakian R; Mishra DR; Preeshagul I; Reddy P; Saxena A; Weinberg F; Kalemkerian GP
    J Clin Oncol; 2023 Dec; 41(35):5448-5472. PubMed ID: 37820295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G
    J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
    Schneider BJ; Daly ME; Kennedy EB; Antonoff MB; Broderick S; Feldman J; Jolly S; Meyers B; Rocco G; Rusthoven C; Slotman BJ; Sterman DH; Stiles BM
    J Clin Oncol; 2018 Mar; 36(7):710-719. PubMed ID: 29106810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
    Kris MG; Gaspar LE; Chaft JE; Kennedy EB; Azzoli CG; Ellis PM; Lin SH; Pass HI; Seth R; Shepherd FA; Spigel DR; Strawn JR; Ung YC; Weyant M
    J Clin Oncol; 2017 Sep; 35(25):2960-2974. PubMed ID: 28437162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.
    Singh N; Temin S; Baker S; Blanchard E; Brahmer JR; Celano P; Duma N; Ellis PM; Elkins IB; Haddad RY; Hesketh PJ; Jain D; Johnson DH; Leighl NB; Mamdani H; Masters G; Moffitt PR; Phillips T; Riely GJ; Robinson AG; Rosell R; Schiller JH; Schneider BJ; Spigel DR; Jaiyesimi IA
    J Clin Oncol; 2022 Oct; 40(28):3310-3322. PubMed ID: 35816666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Masters GA; Temin S; Azzoli CG; Giaccone G; Baker S; Brahmer JR; Ellis PM; Gajra A; Rackear N; Schiller JH; Smith TJ; Strawn JR; Trent D; Johnson DH;
    J Clin Oncol; 2015 Oct; 33(30):3488-515. PubMed ID: 26324367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3.
    Jaiyesimi IA; Owen DH; Ismaila N; Blanchard E; Celano P; Florez N; Jain D; Singh N
    J Clin Oncol; 2023 Apr; 41(11):e31-e41. PubMed ID: 36802359
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2.
    Owen DH; Singh N; Ismaila N; Blanchard E; Celano P; Florez N; Jain D; Leighl NB; Mamdani H; Masters G; Moffitt PR; Naidoo J; Phillips T; Riely GJ; Robinson AG; Schenk E; Schneider BJ; Sequist L; Spigel DR; Jaiyesimi IA
    J Clin Oncol; 2023 Feb; 41(5):e10-e20. PubMed ID: 36534938
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3.
    Jaiyesimi IA; Owen DH; Ismaila N; Blanchard E; Celano P; Florez N; Jain D; Singh N
    J Clin Oncol; 2023 Apr; 41(11):e21-e30. PubMed ID: 36809066
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.
    Owen DH; Singh N; Ismaila N; Blanchard E; Celano P; Florez N; Jain D; Leighl NB; Mamdani H; Masters G; Moffitt PR; Naidoo J; Phillips T; Riely GJ; Robinson AG; Schenk E; Schneider BJ; Sequist L; Spigel DR; Jaiyesimi IA
    J Clin Oncol; 2023 Feb; 41(5):e1-e9. PubMed ID: 36534935
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.1.
    Singh N; Jaiyesimi IA; Ismaila N; Leighl NB; Mamdani H; Phillips T; Owen DH
    J Clin Oncol; 2023 May; 41(15):e42-e50. PubMed ID: 37023367
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1.
    Singh N; Jaiyesimi IA; Ismaila N; Leighl NB; Mamdani H; Phillips T; Owen DH
    J Clin Oncol; 2023 May; 41(15):e51-e62. PubMed ID: 37023387
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2.
    Owen DH; Singh N; Ismaila N; Masters G; Riely GJ; Robinson AG; Schneider BJ; Jaiyesimi IA
    J Clin Oncol; 2023 Aug; 41(24):e63-e72. PubMed ID: 37433095
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
    Singh N; Temin S; Baker S; Blanchard E; Brahmer JR; Celano P; Duma N; Ellis PM; Elkins IB; Haddad RY; Hesketh PJ; Jain D; Johnson DH; Leighl NB; Mamdani H; Masters G; Moffitt PR; Phillips T; Riely GJ; Robinson AG; Rosell R; Schiller JH; Schneider BJ; Spigel DR; Jaiyesimi IA
    J Clin Oncol; 2022 Oct; 40(28):3323-3343. PubMed ID: 35816668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.
    Koyfman SA; Ismaila N; Crook D; D'Cruz A; Rodriguez CP; Sher DJ; Silbermins D; Sturgis EM; Tsue TT; Weiss J; Yom SS; Holsinger FC
    J Clin Oncol; 2019 Jul; 37(20):1753-1774. PubMed ID: 30811281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.